Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 54,536 shares at $40.09 ($2.2M) on 2021-12-08, disclosed to the SEC on 2021-12-10.
Open-market sale of $2.2M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.09 | 24,683 | $990K | 45.3% |
| 2 | $40.09 | 24,683 | $990K | 45.3% |
| 3 | $40.08 | 2,585 | $104K | 4.7% |
| 4 | $40.08 | 2,585 | $104K | 4.7% |
| Total | $40.09 avg | 54,536 | $2.2M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |